Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Moreover, a holistic and personalized approach (considering genomics) can address all the comorbidities to improve and optimize overall health outcomes in CKD
Multiple different parameters of QOL were assessed during the trial, and these parameters did not differ between the 2 groups
Based on asthma and other atopic diseases diagnosed, women in each group were classified into four categories: asthmatics with other coexisting atopic diseases (A-AD), non-asthmatics with other atopic diseases (NA-AD), non-asthmatics without atopic diseases (NA-NAD), and non-asthmatics (NA) (this category includes both non-asthmatics with other atopic disease and non-asthmatics without atopic diseases)
Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia
US$ 21.83
US$ 25.57
US$ 28.13
US$ 28.46
US$ 24.01
US$ 20.87
US$ 25.39
US$ 25.40